Swedish Medical Center Site PI: Gary Goodman MD MS
The Selenium and Vitamin E Cancer Prevention Trial (SELECT) is a research study to determine if selenium and vitamin E can help prevent prostate cancer. SELECT is funded by the National Cancer Institute and coordinated by the Southwest Oncology Group.
As of June 24, 2004 SELECT closed to accrual. Over 35,000 men, from a variety of ethnic groups, including 14% African American, 5% Hispanic, 1% Hispanic African American, and 1% Asian, from over 400 Study Sites in the United States, Puerto Rico, and Canada are participating in SELECT. Dr. Goodman is on the SELECT Steering Committee and PI of the SELECT Study Center at the Swedish Cancer Institute which has accrued over 1,000 participants. See website at http://www.crab.org/select/.